NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001197

Registered date:01/07/2008

Randomized control trial of primary eradication therapies of Helicobacter pylori

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedGastroduodenal ulcer infected by Helicobacter pylori
Date of first enrollment2007/10/01
Target sample size240
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)rabeprazole 10mg bid, amoxicillin 750mg bid and clarithromycin 200mg bid lansoprazole 30mg bid, amoxicillin 750mg bid and clarithromycin 200mg bid

Outcome(s)

Primary OutcomeAssessment of the Helicobacter pylori eradication on the bassis of the urea breath test result
Secondary OutcomeInfluence of the clarithromycin resistance of Helicobacter pylori and the CYP2C19 genotype of the host for the eradication thrapies

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1)Pregnant females 2)Lacting woman 3)Patients who has past history of allergy for the drugs used in this study 4)Patients who has coexisting severe disease 5)Patient whom examination doctor judged improper as testee

Related Information

Contact

public contact
Name Masao Akanuma
Address Japan
Telephone
E-mail makanuma@qd6.so-net.ne.jp
Affiliation The University of Tokyo Hospital Department of Gastroenterology
scientific contact
Name Masao Akanuma
Address 7-3-1 Hongo, Bunkyo-ku, Tokyo Japan
Telephone 03-3815-5411(33070)
E-mail
Affiliation The University of Tokyo Hospital Department of Gastroenterology